Company Filing History:
2 out of 101 
1 out of 2,405 
1 out of 1,829 
Years Active: 2009-2014
Title: Zhenmin He: Innovator in Cyclin Dependent Kinase Inhibitors
Introduction
Zhenmin He is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of cyclin dependent kinase inhibitors. With a total of 2 patents, his work has the potential to impact the treatment of various diseases.
Latest Patents
Zhenmin He's latest patents include innovative compounds such as substituted pyrazolo[1,5-a]pyrimidines. These compounds serve as cyclin dependent kinase inhibitors, providing methods for inhibiting one or more cyclin dependent kinases in patients. The invention outlines a method of administering a therapeutically effective amount of at least one pyrazolo[1,5-a]pyrimidine compound or a pharmaceutical composition containing such a compound. This approach aims to treat, prevent, inhibit, or ameliorate diseases associated with cyclin dependent kinases. Another notable patent involves pyrazolopyrimidines as cyclin dependent kinase inhibitors, detailing a novel class of compounds, methods of preparation, and pharmaceutical formulations.
Career Highlights
Throughout his career, Zhenmin He has worked with reputable companies such as Pharmacopeia Inc. and Merck Sharp & Dohme Corporation. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Zhenmin He has collaborated with notable professionals in the field, including Timothy J Guzi and Kamil Paruch. These collaborations have further enhanced his research and development efforts.
Conclusion
Zhenmin He is a distinguished inventor whose work in cyclin dependent kinase inhibitors showcases his commitment to advancing medical science. His innovative patents and collaborations reflect his significant contributions to the field.